NDC 0069-0315-01
Zirabev 100 mg/4mL
bevacizumab-bvzr · INJECTION, SOLUTION
Zirabev is a injection, solution containing bevacizumab-bvzr at a strength of 100 mg/4mL. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Zirabev
- Generic Name
- bevacizumab-bvzr
- NDC Code (Package)
0069-0315-01- NDC Code (Product)
0069-0315- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761099
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 01/13/2020
Recall History
No Recall HistoryView Full Drug Page
Zirabev — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.